Product Information
FT ANTI-DIARRHEAL 2 MG CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1299 per EA under NDC 70677110601. Its NADAC has been published 144 times since Jan 3, 2024.
FDA first approved this application on Jan 6, 2000.
Strength
2 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677110601
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075232FDA Approved
1/6/2000
On Market Since
11/8/2023
Pharmacological Classes
Price Statistics
The NADAC for FT ANTI-DIARRHEAL 2 MG CAPLET has been published 144 times since Jan 3, 2024, and over the history we have for it it has declined 24.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1299 per EA |
|---|---|
| All-time high | $0.1738 (Feb 14, 2024) |
| All-time low | $0.1233 (Apr 22, 2026) |
| 52-week high | $0.1465 |
| 52-week low | $0.1233 |
| Median price | $0.1344 |
| Average price | $0.1389 |
| Largest weekly change | +22.1% (Jul 17, 2024) |
| Weeks tracked | 144 |
| Tracking since | Jan 3, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loperamide HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ANTI-DIARRHEAL 2 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for FT ANTI-DIARRHEAL 2 MG CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.1299 per EA (NDC 70677110601), effective Sep 30, 2026.
How has the price of FT ANTI-DIARRHEAL 2 MG CAPLET changed over time?
Over the history we have for it, the NADAC for FT ANTI-DIARRHEAL 2 MG CAPLET has declined 24.1%. It has been tracked across 144 weekly CMS publications since Jan 3, 2024.
What are the highest and lowest recorded NADAC prices for FT ANTI-DIARRHEAL 2 MG CAPLET?
Since Jan 3, 2024, the NADAC for FT ANTI-DIARRHEAL 2 MG CAPLET has ranged from a low of $0.1233 (Apr 22, 2026) to a high of $0.1738 (Feb 14, 2024), with a median of $0.1344 per EA.
Are there cheaper alternatives to FT ANTI-DIARRHEAL 2 MG CAPLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT ANTI-DIARRHEAL 2 MG CAPLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FT ANTI-DIARRHEAL 2 MG CAPLET?
FT ANTI-DIARRHEAL 2 MG CAPLET (NDC 70677110601) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.